Maze Therapeutics clinical trials we track

Check company identity source

Phase 2 1 trial

TrialDrugs studiedStatusPrimary completion
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseaseNCT06830629MZE829Recruiting2026-09Estimated

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters